VIVEbiotech participa en el proyecto europeo MAGIC
El consorcio MAGIC pretende
tener un impacto significativo en la vida de personas afectadas por distrofias musculares.
VIVEbiotech participa en el proyecto europeo MAGIC
CRISPR-Cas:From biology to therapeutic
Global Awards for Research in DMD-AWARD
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network
Four post-doc positions (assistant researcher) available
WADA invites applications for research projects on the development of gene doping detection methods
Nuestras cifras y logros del 2022
FDA approval of the world’s first gene therapy for Haemophilia
2022 - Sevilla
Immunotherapy and Cell Therapy Course, Madrid
SETGYC 2022 Oral and Poster Award Winners
Outreach opportunity as a translator for EuroGCT
In memory of Dr. Manfred Schmidt
A vacancy or course to advertise?
2019-Barcelona
2018-Mallorca
2017-Granada
2015-San Sebastian
2013-Madrid
2011-Zaragoza